---
schema_version: "secwatch.filing_event.v1"
accession: "0000898432-21-000732"
form_type: "8-K"
ticker: "IRMD"
cik: "0001325618"
company_name: "IRADIMED CORP"
filed_at: "2021-11-23T23:59:59+00:00"
generated_at: "2026-06-28T05:42:01.319529+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# CEO Roger Susi enters new 10b5-1 plan to sell shares over 12 months

## Summary
- Plan replaces prior June 2021 plan; allows daily sales from Nov 22, 2021 to Nov 21, 2022.
- Sales subject to minimum market price threshold; executed shares disclosed via Form 4 filings.
- Purpose: increase public float in a non-dilutive manner.
- Plan terminates on earlier of Nov 21, 2022, full execution, or termination.

## SEC filing metadata
- accession: 0000898432-21-000732
- form_type: 8-K
- ticker: IRMD
- cik: 0001325618
- company_name: IRADIMED CORP
- filed_at: 2021-11-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1325618/000089843221000732/0000898432-21-000732-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1325618/000089843221000732/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000898432-21-000732
- JSON: https://secwatch.observer/filing/0000898432-21-000732.json
- Plain text: https://secwatch.observer/filing/0000898432-21-000732.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.